A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

NCT00587015 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
50
Enrollment
INDUSTRY
Sponsor class

Stopped Due to a lack of IP supply and then terminated because they were combined into one new study with the new IP formulation.

Conditions

Interventions

Sponsor

MedImmune LLC